Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Clinical Laserthermia Systems AB's FCF Yield % or its related term are showing as below:
FRA:LS60'
s FCF Yield % Range Over the Past 10 Years
Min: -192.05 Med: -23.48 Max: -3.76
Current: -35.43
During the past 13 years, the highest FCF Yield % of Clinical Laserthermia Systems AB was -3.76%. The lowest was -192.05%. And the median was -23.48%.
FRA:LS60's FCF Yield % is ranked worse than 88.86% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: -0.44
vs FRA:LS60: -35.43
Clinical Laserthermia Systems AB FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Clinical Laserthermia Systems AB FCF Yield % Related Terms
Clinical Laserthermia Systems AB FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinical Laserthermia Systems AB FCF Yield % Chart
For the Medical Devices subindustry, Clinical Laserthermia Systems AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinical Laserthermia Systems AB FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Clinical Laserthermia Systems AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinical Laserthermia Systems AB (FRA:LS60) has a FCF Yield % of -35.43 as of Jul. 20, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Clinical Laserthermia Systems AB and its competitors. According to the industry distribution chart, Clinical Laserthermia Systems AB ranks #758 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 88.9%.
Is Clinical Laserthermia Systems AB's FCF Yield % too high?
Clinical Laserthermia Systems AB's current FCF Yield % is -35.43. Based on the distribution chart, Clinical Laserthermia Systems AB ranks #758 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Clinical Laserthermia Systems AB has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clinical Laserthermia Systems AB's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Clinical Laserthermia Systems AB ranks #758 out of 853 companies for FCF Yield %. This places Clinical Laserthermia Systems AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Clinical Laserthermia Systems AB and its competitors. Clinical Laserthermia Systems AB's current FCF Yield % is -35.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinical Laserthermia Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB (FRA:LS60) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.28, compared to a current price of €0.24 — trading 12.9% below its estimated fair value. The current FCF Yield % is -35.43. Clinical Laserthermia Systems AB's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Clinical Laserthermia Systems AB (FRA:LS60), the current FCF Yield % is -35.43 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued.
The current stock price of €0.24 is trading 12.9% below its estimated GF Value™ of €0.28.
GuruFocus considers Clinical Laserthermia Systems AB to be Modestly Undervalued.
Key valuation signals for FRA:LS60:
FCF Yield %: -35.43
GF Value™: €0.28 vs. price of €0.24 (12.9% below fair value)
No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clinical Laserthermia Systems AB Business Description
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
42GF Score
Get the complete analysis for FRA:LS60
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LS60 has been successfully added to your 
